These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1293 related articles for article (PubMed ID: 12850810)
1. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo. Rodrigues EG; Garofalo AS; Travassos LR Cytokines Cell Mol Ther; 2002; 7(3):107-16. PubMed ID: 12850810 [TBL] [Abstract][Full Text] [Related]
2. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma. Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448 [TBL] [Abstract][Full Text] [Related]
3. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. Salkowski CA; Kopydlowski K; Blanco J; Cody MJ; McNally R; Vogel SN J Immunol; 1999 Aug; 163(3):1529-36. PubMed ID: 10415056 [TBL] [Abstract][Full Text] [Related]
4. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice. Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-gamma is associated with the activation of extracellular signal-related kinase. Zhu YN; Yang YF; Ono S; Zhong XG; Feng YH; Ren YX; Ni J; Fu YF; Tang W; Zuo JP Int Immunol; 2006 Jun; 18(6):981-90. PubMed ID: 16636012 [TBL] [Abstract][Full Text] [Related]
6. Subtherapeutic doses of interleukin-15 augment the antitumor effect of interleukin-12 in a B16F10 melanoma model in mice. Lasek W; Golab J; Maśliński W; Switaj T; Bałkowiec EZ; Stokłosa T; Giermasz A; Malejczyk M; Jakóbisiak M Eur Cytokine Netw; 1999 Sep; 10(3):345-56. PubMed ID: 10477391 [TBL] [Abstract][Full Text] [Related]
7. Modulation of IFN-gamma production by TNF-alpha in macrophages from the tumor environment: significance as an angiogenic switch. Lee H; Baek S; Joe SJ; Pyo SN Int Immunopharmacol; 2006 Jan; 6(1):71-8. PubMed ID: 16332515 [TBL] [Abstract][Full Text] [Related]
8. Role of interferon-gamma in interleukin 12-induced pathology in mice. Car BD; Eng VM; Schnyder B; LeHir M; Shakhov AN; Woerly G; Huang S; Aguet M; Anderson TD; Ryffel B Am J Pathol; 1995 Dec; 147(6):1693-707. PubMed ID: 7495294 [TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in murine macrophages. Lakics V; Vogel SN J Immunol; 1998 Sep; 161(5):2490-500. PubMed ID: 9725248 [TBL] [Abstract][Full Text] [Related]
10. Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice. Kamijo R; Shapiro D; Gerecitano J; Le J; Bosland M; Vilcek J Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1332-8. PubMed ID: 7705746 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate. Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120 [TBL] [Abstract][Full Text] [Related]
12. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity. Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946 [TBL] [Abstract][Full Text] [Related]
13. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells. Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292 [TBL] [Abstract][Full Text] [Related]
14. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice. Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971 [TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of CH50 on macrophage activation and its anti-tumor activity with those of lipopolysaccharides. Zhang GM; Feng ZH; Li D; Zhang H Acta Pharmacol Sin; 2000 Jun; 21(6):567-70. PubMed ID: 11360693 [TBL] [Abstract][Full Text] [Related]
16. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice. Comes A; Di Carlo E; Musiani P; Rosso O; Meazza R; Chiodoni C; Colombo MP; Ferrini S Eur J Immunol; 2002 Jul; 32(7):1914-23. PubMed ID: 12115611 [TBL] [Abstract][Full Text] [Related]
17. [Antitumor effect of M-CSF and/or IFN-gamma gene cotransfected-macrophages by intratumoral injection]. Lei H; Cao X; Yu Y Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):174-7. PubMed ID: 10920999 [TBL] [Abstract][Full Text] [Related]
18. Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis. Rogers HW; Tripp CS; Schreiber RD; Unanue ER J Immunol; 1994 Sep; 153(5):2093-101. PubMed ID: 8051414 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons. Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627 [TBL] [Abstract][Full Text] [Related]
20. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine. Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]